Financials

News Ideas Technicals

214870 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to NEWGLAB PHARMA operating, investing, and financing activities

214870 free cash flow for Q4 23 is -7.14 B KRW. For 2023, 214870 free cash flow was -13.81 B KRW and operating cash flow was -13.4 B KRW.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: KRW

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—